In a patient with low‑normal TSH, normal total T4, and critically low T3, what does a low or inappropriately normal morning ACTH level indicate and how should it be evaluated?

Low or Inappropriately Normal Morning ACTH in the Setting of Low T3 and Normal TSH/T4

A low or inappropriately normal morning ACTH level in this clinical context strongly suggests central adrenal insufficiency (CAI) as part of hypopituitarism, and you must proceed with confirmatory ACTH stimulation testing while simultaneously evaluating for a structural pituitary lesion. 1

What This Indicates

The combination of:

• Low-normal TSH with critically low T3 (suggesting central hypothyroidism)
• Low or inappropriately normal morning ACTH

...points to pituitary dysfunction affecting multiple axes (corticotroph and thyrotroph). In primary adrenal insufficiency, ACTH would be markedly elevated; a low or "normal" ACTH in the face of suspected hypocortisolism is pathologically inappropriate and indicates the pituitary is failing to respond to low cortisol feedback 1.

Key Pathophysiologic Point

The thyroid pattern described (low-normal TSH, normal T4, critically low T3) is atypical for primary thyroid disease and suggests central hypothyroidism, where TSH may be low-normal or even mildly elevated but biologically inactive. When you see this pattern alongside abnormal ACTH dynamics, you're dealing with panhypopituitarism or evolving hypopituitarism 2, 3.

Diagnostic Evaluation Algorithm

Step 1: Morning Cortisol Measurement

Obtain an 8 AM cortisol level alongside the ACTH:

• Cortisol <3.6 μg/dL (<100 nmol/L): Confirms adrenal insufficiency; proceed directly to glucocorticoid replacement 1
• Cortisol 3.6-12.6 μg/dL (100-350 nmol/L): Indeterminate; requires ACTH stimulation testing 1
• Cortisol >12.6 μg/dL (>350 nmol/L): Excludes adrenal insufficiency with high confidence 1

More recent data using second-generation assays suggests slightly lower thresholds: cortisol ≤60.9 μg/L predicts CAI with 96.3% specificity, while >141 μg/L excludes it with 96.2% sensitivity 4.

Step 2: ACTH Stimulation Testing

Use the standard 250 μg cosyntropin test performed in the early morning 1, 5:

• Administer 250 μg ACTH (1-24) intravenously
• Measure cortisol at 0,30, and 60 minutes
• Peak cortisol <18 μg/dL (<500 nmol/L) confirms adrenal insufficiency 1
• Peak cortisol >18 μg/dL excludes it

Critical caveat: The 1 μg low-dose test is NOT appropriate here. It's designed for detecting subtle primary adrenal insufficiency, not central AI. The standard 250 μg dose is the criterion standard and prevents false positives 5.

Step 3: Pituitary Imaging

Obtain MRI of the pituitary with gadolinium contrast immediately 2:

• 31% of pituitary incidentalomas present with hormone deficiency in at least one axis
• Macroadenomas (>10 mm) significantly increase risk of hypopituitarism (OR 3.38) 2
• However, 3% of patients develop worsening pituitary dysfunction even without adenoma growth, so normal imaging doesn't exclude the diagnosis 2

Look specifically for:

• Pituitary adenomas (especially non-functioning macroadenomas)
• Rathke's cleft cysts
• Craniopharyngiomas
• Empty sella syndrome
• Infiltrative processes (sarcoidosis, hypophysitis)

Step 4: Complete Pituitary Axis Evaluation

Test all other pituitary axes since multiple deficiencies commonly coexist 2:

• Gonadotropins: LH, FSH, testosterone (men) or estradiol (women)
• Growth hormone: IGF-1 (dynamic testing if clinically indicated)
• Prolactin: May be elevated with stalk compression or low with extensive pituitary damage
• Free T4 and free T3: Already abnormal in your patient

Management Priorities

Immediate Actions

1. Start glucocorticoid replacement BEFORE thyroid hormone replacement 6. This is critical: treating hypothyroidism first in a patient with concurrent adrenal insufficiency can precipitate adrenal crisis by increasing cortisol metabolism.

2. Hydrocortisone 15-25 mg daily in divided doses (typically 10 mg morning, 5 mg afternoon, 5 mg evening) or equivalent 1

3. Only after cortisol replacement is established, begin levothyroxine for central hypothyroidism (typically lower doses than primary hypothyroidism, titrated to free T4 in upper-normal range, NOT TSH) 6, 3

Common Pitfalls to Avoid

• Don't rely on TSH alone: In central hypothyroidism, TSH may be low-normal, normal, or even mildly elevated but biologically inactive 7, 3. The case report of an 87-year-old woman with pituitary tumor illustrates how repeatedly normal TSH levels missed significant hypothyroidism 3.

• Don't use the 1 μg ACTH test: It has no role in suspected central AI and can produce false positives 5

• Don't order ACTH stimulation testing in septic shock: This is an inappropriate indication; the test doesn't predict benefit from steroids in sepsis 8

• Don't assume stable imaging means stable function: 5.2% of patients with stable or decreasing pituitary lesion size still develop new hormone deficiencies 2

Follow-up Monitoring

• Repeat pituitary imaging in 6-12 months if initial imaging shows an adenoma or other lesion 2
• Annual endocrine reassessment even with stable imaging, as new hormone deficiencies occur at 1.2-2.4 per 100 person-years (up to 11.9 for some macroadenomas) 2
• Monitor for development of additional axis deficiencies, particularly gonadotropin deficiency (most common at presentation) 2

Evidence Quality Note

The diagnostic thresholds for morning cortisol are based on moderate-quality evidence comparing cortisol levels to ACTH stimulation test results 1. The 2024 European Society of Endocrinology/Endocrine Society joint guideline provides the most authoritative current recommendations 1, with 2026 data refining thresholds for second-generation assays 4. The 2025 Pituitary Society consensus on incidentalomas provides the most recent guidance on structural evaluation and natural history 2.